418 related articles for article (PubMed ID: 29338854)
21. Reproductive outcomes of familial oocyte donation.
Hasson J; Tulandi T; Son WY; Al Ma'mari N; Badeghiesh A; Tannus S; Takefman J; Shavit T
Fertil Steril; 2016 Dec; 106(7):1696-1702. PubMed ID: 27678040
[TBL] [Abstract][Full Text] [Related]
22. Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence.
Kristensen SG; Giorgione V; Humaidan P; Alsbjerg B; Bjørn AB; Ernst E; Andersen CY
Fertil Steril; 2017 May; 107(5):1206-1213. PubMed ID: 28433369
[TBL] [Abstract][Full Text] [Related]
23. Do Patient Characteristics Decide if Young Adult Cancer Patients Undergo Fertility Preservation?
Flink DM; Sheeder J; Kondapalli LA
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):223-228. PubMed ID: 27893303
[TBL] [Abstract][Full Text] [Related]
24. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
25. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
26. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
27. Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes?
Pereira N; Amrane S; Estes JL; Lekovich JP; Elias RT; Chung PH; Rosenwaks Z
Fertil Steril; 2016 Feb; 105(2):539-44.e1. PubMed ID: 26604066
[TBL] [Abstract][Full Text] [Related]
28. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
[TBL] [Abstract][Full Text] [Related]
29. Fertility preservation for social indications: a cost-based decision analysis.
Hirshfeld-Cytron J; Grobman WA; Milad MP
Fertil Steril; 2012 Mar; 97(3):665-70. PubMed ID: 22265038
[TBL] [Abstract][Full Text] [Related]
30. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
[TBL] [Abstract][Full Text] [Related]
31. Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies.
Barton SE; Missmer SA; Berry KF; Ginsburg ES
Fertil Steril; 2012 Feb; 97(2):381-6. PubMed ID: 22177464
[TBL] [Abstract][Full Text] [Related]
32. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
Jones G; Hughes J; Mahmoodi N; Smith E; Skull J; Ledger W
Hum Reprod Update; 2017 Jul; 23(4):433-457. PubMed ID: 28510760
[TBL] [Abstract][Full Text] [Related]
33.
Woodard TL; Hoffman AS; Crocker LC; Holman DA; Hoffman DB; Ma J; Bassett RL; Leal VB; Volk RJ
BMJ Open; 2018 Feb; 8(2):e019994. PubMed ID: 29467138
[TBL] [Abstract][Full Text] [Related]
34. Professionals' barriers in female oncofertility care and strategies for improvement.
van den Berg M; Baysal Ö; Nelen WLDM; Braat DDM; Beerendonk CCM; Hermens RPMG
Hum Reprod; 2019 Jun; 34(6):1074-1082. PubMed ID: 31111876
[TBL] [Abstract][Full Text] [Related]
35. Cancer Survivors' Use of Fertility Preservation.
Bann CM; Treiman K; Squiers L; Tzeng J; Nutt S; Arvey S; McGoldrick D; Rechis R
J Womens Health (Larchmt); 2015 Dec; 24(12):1030-7. PubMed ID: 26375046
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of ovarian tissue transplantation: results from three clinical centers.
Shapira M; Dolmans MM; Silber S; Meirow D
Fertil Steril; 2020 Aug; 114(2):388-397. PubMed ID: 32605799
[TBL] [Abstract][Full Text] [Related]
37. Oncofertility and Pregnancy in Adolescent and Young Adult Cancers: Physicians' Knowledge and Preferences in India.
Mailankody S; Bajpai J; Arora PR; Sreedharan R; Chitalkar P; Kurkure P; Malhotra H; Parikh FR; Gupta S; Banavali SD
JCO Glob Oncol; 2024 Jan; 10():e2300205. PubMed ID: 38207248
[TBL] [Abstract][Full Text] [Related]
38. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with the receipt of fertility preservation services along the decision-making pathway in young Canadian female cancer patients.
Yee S
J Assist Reprod Genet; 2016 Feb; 33(2):265-80. PubMed ID: 26560157
[TBL] [Abstract][Full Text] [Related]
40. A Study Protocol for the Australasian Oncofertility Registry: Monitoring Referral Patterns and the Uptake, Quality, and Complications of Fertility Preservation Strategies in Australia and New Zealand.
Anazodo AC; Stern CJ; McLachlan RI; Gerstl B; Agresta F; Cohn RJ; Jayasinghe Y; Wakefield CE; Daly G; Chan D; Gilbert L; Kemertzis M; Orme LM; Wand H; Viney R; Gillam L; Deans R; Jetti M; Wu J; Chapman M; Ledger W; Sullivan EA
J Adolesc Young Adult Oncol; 2016 Sep; 5(3):215-25. PubMed ID: 26981848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
